Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia

NCT01389167 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01389167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01389167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
Lead sponsor
Yale University
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2011
Completion date
May 31, 2017
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opiate dependence